Annual CFF
$12.72 M
+$12.67 M+21763.23%
31 December 2023
Summary:
Biodexa Pharmaceuticals annual cash flow from financing activities is currently $12.72 million, with the most recent change of +$12.67 million (+21763.23%) on 31 December 2023. During the last 3 years, it has risen by +$8.77 million (+221.47%). BDRX annual CFF is now -77.49% below its all-time high of $56.54 million, reached on 01 December 2014.BDRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDRX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | - | - |
| 3 y3 years | +221.5% | - | - |
| 5 y5 years | +247.4% | - | - |
BDRX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | ||||
| 5 y | 5 years | -46.8% | +247.4% | ||||
| alltime | all time | -77.5% | +247.4% |
Biodexa Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $12.72 M(>+9900.0%) | - | - |
| Dec 2022 | $58.20 K(-99.5%) | - | - |
| Dec 2021 | $12.11 M(+206.0%) | - | - |
| Dec 2020 | $3.96 M(-83.5%) | - | - |
| Dec 2019 | $23.92 M(-377.0%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$8.64 M(-165.1%) | - | - |
| Dec 2017 | $13.27 M(-35.8%) | - | - |
| Dec 2016 | $20.67 M(-6275.4%) | - | - |
| Dec 2015 | -$334.70 K(-100.6%) | - | - |
| Dec 2014 | $56.54 M(+436.2%) | - | - |
| Dec 2013 | $10.55 M | - | - |
FAQ
- What is Biodexa Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual CFF year-on-year change?
What is Biodexa Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of BDRX is $12.72 M
What is the all time high annual CFF for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual cash flow from financing activities is $56.54 M
What is Biodexa Pharmaceuticals annual CFF year-on-year change?
Over the past year, BDRX annual cash flow from financing activities has changed by +$12.67 M (+21763.23%)